From: Benign intracranial hypertension associated to blood coagulation derangements
Patients | Healthy Controls | P value | |
---|---|---|---|
PT(sec) | 12 ± 0,5 | 11,5 ± 0,8 | 0.18, ns |
aPTT (sec) | 30 ± 2,5 | 31,5 ± 3,4 | 0.09, ns |
Fibrinogen (mg/dl) | 340 ± 80,7 | 360 ± 68,2 | 0.32, ns |
ATIII (%) | 72 ± 16,5 | 76 ± 14,7 | 0.34, ns |
PG (%) | 80 ± 14,7 | 74,5 ± 15,2 | 0.19, ns |
t-PA(ng/ml) | 6,8 ± 3,7 | 7,5 ± 4,8 | 0.58, ns |
PAI-l(ng/ml) | 45.7 ± 12.5 | 8.5 ± 6.7 | < 0.0001, s |
FPA (ng/ml) | 8.7 ± 2.5 | 2.2 ± 1.25 | < 0.0001, s |
F1+2 (nM/l) | 5.7 ± 1.15 | 0.45 ± 0.35 | 0.0001, s |
D-dimers (ng/ml) | 375 ± 65 | 225 ± 75 | < 0.0001, s |
PC(%) | 64 ± 7.5 | 87 ± 14.5 | < 0.0001, s |
PS (%) | 97 ± 23 | 103 ± 12 | 0.16, ns |
Aβ2IgM (UM/l) | 14.5 ± 6.8 | 0.38 ± 0.25 | < 0.0001, s |
Aβ2IgG(UG/l) | 22.5 ± 11.5 | 0.58 ± 0.30 | < 0.0001, s |